AzTrials
AzTrials

Appetitive AggressionNCT02992561

Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means

A study testing FORNET (adapted version) in people with Appetitive Aggression, run by University of Konstanz at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heightened levels of aggression are fuelling violent incidents at all levels, especially in post-war regions. Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) aims to address trauma symptoms along with reactive and instrumental/appetitive aggression to encounter the downward cycle of… Read more about this study

Who is it for?
Ages 16 to 80 years
Conditions the study is for
Appetitive Aggression
What is being tested?
FORNET (adapted version)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
402 participants
Where
1 siteGermany
Study dates
Sep 2016to Mar 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 80 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • PTSD diagnosis or AAS sum score of 22 or higher

Who cannot join

  • Acute intoxification (alcohol or other drugs)
  • Acute psychotic symptoms
  • Sign of cerebro-organic diseases

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University of Konstanz

    Konstanz, Baden-Wurttemberg, 78464

Other trials in Germany

About this study

Official title: Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means: A Randomized Controlled Trial in Eastern DR Congo

Heightened levels of aggression are fuelling violent incidents at all levels, especially in post-war regions. Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) aims to address trauma symptoms along with reactive and instrumental/appetitive aggression to encounter the downward cycle of perpetration and enforce a sustainable (re-)integration into civil life. In the present study, the investigators provide an adapted version of FORNET to former combatants in the North Kivu, Eastern DR Congo. Structured baseline, 3 and 6 month follow up interviews will be administered to assess the main outcome measures recent violent acts and appetitive aggression.

Read the detailed description

Participants will be recruited through local NGOs and eligible clients randomized to the treatment or waitlist control group, respectively. The treatment will be provided by supervised local counsellors after a 4-week training. At baseline, 3-month and 6-month follow up, sociodemographic data, trauma exposure, perpetrated violent acts, PTSD, recent aggression, functionality and drug dependency will be assessed. The interviews will be conducted by blind Congolese psychological interviewers after an intensive 3-weeks training and continuous supervision.

Being tested
FORNET (adapted version)
Keywords
Aggression, Violence, Post-conflict reconstruction, Demobilization, Traumatized offenders
Medical subject headings
Aggression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FORNET (adapted version)Behavioural

    Also called Narrative Exposure Therapy for Forensic Offender Rehabilitation (adapted version)

Study groups in NCT02992561
Study groupRoleWhat they receive
Narrative Exposure Therapy (FORNET, adapted version)Active comparatorVersion of Narrative Exposure Therapy for Forensic Offender Rehabilitation including one lifeline session and 5 exposure sessions as well as 6 group sessions adapted from behavioral-therapy approaches for addiction problems.
Receives: Behavioral: FORNET (adapted version)
Waitlist control or treatment as usualNo interventionNo intervention or non-specific measures of support on request

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Appetitive aggression (sumscore; 0-60 indicating higher levels)

    Appetitive Aggression Scale (Weierstall \& Ebert, 2011)

    Measured: Change from baseline to 3-5 and 6-9 months post treatment

  2. Current violent behavior (sumscore; 0-96 indicating more acts)

    A list of violent offenses perpetrated during the last 3 months (formerly used in Burundi; Crombach/Augsburger/Nandi)

    Measured: Change from baseline to 3-5 and 6-9 months post treatment

Secondary outcomes (1)
  1. PSS-I: Posttraumatic Stress Disorder (sumscore, 0-80 indicating higher severity)

    PTSD Symptom Scale (Foa \& Tolin, 2000)

    Measured: Change from baseline to 3-5 and 6-9 months post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionMar 2019
  4. Study completionMar 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
402 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02992561
Sponsor's protocol ID
FORNET1617
Status last verified
Jul 2020
First submitted
6 Dec 2016
Last updated
4 Aug 2020
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Carleial S, Natt D, Unternahrer E, Elbert T, Robjant K, Wilker S, Vukojevic V, Kolassa IT, Zeller AC, Koebach A. DNA methylation changes following narrative exposure therapy in a randomized controlled trial with female former child soldiers. Sci Rep. 2021 Sep 16;11(1):18493. doi: 10.1038/s41598-021-98067-9.

    PubMed 34531495
  • Koebach A, Carleial S, Elbert T, Schmitt S, Robjant K. Treating trauma and aggression with narrative exposure therapy in former child and adult soldiers: A randomized controlled trial in Eastern DR Congo. J Consult Clin Psychol. 2021 Mar;89(3):143-155. doi: 10.1037/ccp0000632.

    PubMed 33829803
  • Robjant K, Koebach A, Schmitt S, Chibashimba A, Carleial S, Elbert T. The treatment of posttraumatic stress symptoms and aggression in female former child soldiers using adapted Narrative Exposure therapy - a RCT in Eastern Democratic Republic of Congo. Behav Res Ther. 2019 Dec;123:103482. doi: 10.1016/j.brat.2019.103482. Epub 2019 Sep 27.

    PubMed 31639529

Questions about this trial

What is this clinical trial studying?

A study testing FORNET (adapted version) in people with Appetitive Aggression, run by University of Konstanz at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Appetitive aggression (sumscore; 0-60 indicating higher levels) (time frame: Change from baseline to 3-5 and 6-9 months post treatment). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02992561, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in